Adolescent TMS Therapy

About Magstim

Founded in 1992, Magstim is a pioneering private company in the neurotechnology and medical device sector, with a 30+ year history. It operates a commercial-stage business model, generating revenue from the sale of its TMS, EEG, and tDCS systems to research institutions and clinical providers globally. The company's technology is clinically validated, with its TMS systems forming the basis for FDA-cleared treatments for conditions like Major Depressive Disorder (MDD). Magstim's strategy focuses on expanding clinical indications for its neuromodulation platforms and integrating its modalities for advanced brain research and therapy.

Therapeutic Areas